Name | 5'-Fluoro-2'-hydroxyacetophenone |
Synonyms | 2-Acety-4-fluorophenol 2-Acetyl-4-fluorophenol 1-(5-FLUORO-2-HYDROXY-P Hydroxyphenyl)ethan-1-one 5'-Fluoro-2'-hydroxyacetopheno 2-HYDROXY-5-FLUOROACETOPHENONE 5-FLUORO-2-HYDROXYACETOPHENONE 5'-fluoro-2'-hydroxy-acetophenon 5'-FLUORO-2'-HYDROXYACETOPHENONE 5'-fluoro-2'-hydroxy-acetophenon 5'-Fluoro-2'-hydroxyacetophenone 2'-hydroxy-5'-fluoroacetophenone 1-(5-FLUORO-2-HYDROXY-PHENYL)ETHANONE 5-Fluoro-2-hydroxyphenyl(methyl) ketone Ethanone, 1-(5-fluoro-2-hydroxyphenyl)- 1-(5-FLUORO-2-HYDROXYPHENYL)-1-ETHANONE 1-(5-FLUORO-2-HYDROXYPHENYL)ETHAN-1-ONE 5'-Fluoro-2'-Hydroxyacetophenone 1-(5-Fluoro-2- 5'-fluoro-2'-hydroxyacetophenone,1-(5-fluoro-2-hydroxy)ethanone |
CAS | 394-32-1 |
EINECS | 206-893-5 |
InChI | InChI=1/C6H4FNO3/c7-4-1-2-6(9)5(3-4)8(10)11/h1-3,9H |
Molecular Formula | C8H7FO2 |
Molar Mass | 154.14 |
Density | 1.1850 (estimate) |
Melting Point | 56-58°C(lit.) |
Boling Point | 65-66°C8mm Hg(lit.) |
Flash Point | 65-66°C/8mm |
Water Solubility | Soluble 0.68 G/L |
Vapor Presure | 0.0353mmHg at 25°C |
Appearance | Bright yellow to light brown crystals or powder |
Color | White to Gray to Brown |
BRN | 2359087 |
pKa | 10.17±0.18(Predicted) |
Storage Condition | Inert atmosphere,Room Temperature |
Refractive Index | 1.581 |
MDL | MFCD00011668 |
Physical and Chemical Properties | Almost white crystalline powder. |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R22 - Harmful if swallowed |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S37/39 - Wear suitable gloves and eye/face protection S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
WGK Germany | 3 |
RTECS | AM8502300 |
HS Code | 29147000 |
Hazard Class | IRRITANT |
NIST chemical information | Information provided by: webbook.nist.gov (external link) |
use | 5-fluoro -2-hydroxyacetophenone, alias 2-acetyl -4-fluorophenol, is an important pharmaceutical intermediate, can be used as a variety of β receptor blocker synthesis intermediate, has broad market prospects. |